Investors Rotate Into Bonds and Defensive Healthcare Stocks Amid Deepening Tech Selloff

Investors are fleeing high-momentum technology and artificial intelligence equities, rotating capital into defensive healthcare stocks and U.S. government bonds amid mounting risk aversion. U.S. Treasuries staged their largest single-day advance in at least a year, sending yields sharply lower across the curve. Simultaneously, major biopharmaceutical companies traded near all-time highs. In recent market action, Eli Lilly surged 4.88%, UnitedHealth Group advanced 3.67%, Gilead Sciences climbed 3.42%, Amgen gained 3.19%, and AbbVie added 1.20% to reach record levels as market participants seek out resilient balance sheets and reliable cash flows.